Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.74% | $27.45M | €338.67B | 38.66% | 76 Outperform | |
| AstraZeneca | 2.61% | $26.17M | $275.76B | 38.00% | 75 Outperform | |
| Rolls-Royce Holdings | 1.93% | $19.33M | £89.61B | 104.42% | 71 Outperform | |
| UniCredit SpA | 1.79% | $17.87M | €96.51B | 75.92% | 75 Outperform | |
| ― | 1.49% | $14.87M | ― | ― | ― | |
| Roche Holding AG | 1.45% | $14.54M | CHF248.32B | 34.30% | 73 Outperform | |
| Unilever | 1.41% | $14.11M | £109.80B | -1.32% | 77 Outperform | |
| Sony | 1.33% | $13.34M | ¥26.47T | 59.23% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 1.29% | $12.95M | ¥26.63T | 39.45% | 76 Outperform | |
| Prosus | 1.29% | $12.87M | €126.70B | 64.24% | 77 Outperform |